Transposagen Biophamaceuticals

Transposagen Biophamaceuticals Overview

Founded 2003
Founded
Status Private
Employees 20
Employees
Latest Deal Type Grant
Latest Deal Amount $4.3M
Latest Deal Amount
Investors 1

Transposagen Biophamaceuticals General Information

Description

Developer of animal models, cell lines, stem cells, research tools and technologies to improve drug discovery and development research. The company is biotechnology based and provides genetically modified rat models to pharmaceutical and biotechnology companies, academic laboratories and the National Institutes of Health.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 535 West Second Street
  • Suite L102
  • Lexington, KY 40508
  • United States
+1 (859) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Transposagen Biophamaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 21-Jun-2013 $4.3M 00.000 Completed Generating Revenue
3. Angel (individual) 18-Jul-2012 00000 00.000 Completed Generating Revenue
2. Angel (individual) 20-Dec-2011 $725K $725K Completed Generating Revenue
1. Accelerator/Incubator Completed Startup

Transposagen Biophamaceuticals Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
Caribou Biosciences Venture Capital-Backed Berkeley, CA 00 000.00 00000000000 000.00
00000000 Venture Capital-Backed Redwood City, CA 000 00000 00000000000 00000
0000000 Corporation Seoul, South Korea 00
000000 00000000000 Formerly VC-backed Zug, Switzerland 000 00000 00000000000 00000
000000000 Formerly VC-backed Piscataway Township, NJ 0000 00000 00000000 00000

Transposagen Biophamaceuticals Executive Team (1)

Name Title Board Seat Contact Info
Eric Ostertag Ph.D Chief Executive Officer & President

Transposagen Biophamaceuticals Board Members (1)

Name Representing Role Since
Nishan Silva MD Self Board Member 000 0000

Transposagen Biophamaceuticals Investors (1)

To view Transposagen Biophamaceuticals‘s full investor history, request access >>
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Johns Hopkins Technology Ventures Accelerator/Incubator 000 0000 000000 0

Ready to get started?

Request a free trial